Moonshot AI targets $2 billion in annualized sales by the end of 2026.
The AMW Read
Adds a concrete revenue target that sharpens the valuation debate around Moonshot's already-disclosed Hong Kong IPO without resolving it.
Moonshot AI targets $2 billion in annualized sales by the end of 2026.
The Kimi-maker's leadership has set a goal of reaching $2 billion in annualized revenue by year-end 2026, according to Tech in Asia. The company, founded in 2023 and now one of China's best-funded foundation-model labs with $1.77 billion in disclosed funding, has spent 2026 stacking headline-grabbing milestones: a $3.5 billion round that valued it at $35 billion, a subsequent report of a $160 billion valuation tied to its flat organizational structure, and continued momentum around its Kimi K3 model.
The revenue figure lands squarely inside Moonshot's ongoing Hong Kong IPO process. The company has confidentially filed to raise up to $5 billion, with Goldman Sachs and Bank of America now on board as underwriters, and has floated a $50 billion valuation target via a pre-IPO round. A $2 billion run-rate by the end of 2026 would put that ask at roughly 25 times forward revenue — an aggressive multiple even against frontier-lab comparables — and puts real pressure on Kimi's subscription and enterprise-API monetization to scale fast. It also places Moonshot alongside DeepSeek and Alibaba's Qwen in the race to convert Chinese model releases into durable commercial revenue rather than usage share alone, a race now extending into Japan following Kimi's paid-plan launch there in August.
For IPO investors, the revenue target becomes the number to track against actual disclosures as the listing proceeds — a miss would undercut the valuation case built on the $160 billion narrative. For builders integrating Kimi's API, a public revenue push of this scale is typically followed by pricing and capacity changes as the company optimizes for monetization over growth. Per the AI Market Watch index, newsflow on Moonshot AI has accelerated to 41 tracked items in the past 90 days versus 25 in the prior period (coverage limited to pipeline-ingested sources), consistent with a company now moving through IPO-adjacent disclosure cycles.


